FDA
approval
· 2022-01-21
FDA Approved: TRI-LO-MILI — Supplemental Application (Aurobindo Pharma Limited)
Summary
FDA approved a supplemental application for TRI-LO-MILI (norgestimate and ethinyl estradiol) by Aurobindo Pharma Limited, authorizing its continued marketing as…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TRI-LO-MILI (NORGESTIMATE AND ETHINYL ESTRADIOL)